Actemra Has a Record of Heart Attacks, Strokes and Death
National Personal Injury Law Firm | Helping victims with their Actemra Lawsuit
Rheumatoid arthritis (RA) drug Actemra (tocilizumab) has been implicated in more than a thousand deaths. When introduced to the U.S. market in 2010, patients and doctors were never warned of the risks of heart attacks, heart failure, stroke, pancreatitis and lung disease by the drug maker.
Genentech, a subsidiary of Roche, failed to warn of potential serious side effects or the possibility of death. Since its approval in 2010, the Food and Drug Administration (FDA) received thousands of complaints about the intravenous injection.
If you or someone you know has been affected by Actemra, Greg Jones Law is currently taking cases regarding serious side effects of this drug. Contact us today for a free case evaluation.
Actemra is indicated for rheumatoid arthritis in adults, but may also be used to treat an artery problem known as giant cell arteritis (GCA) and other types of arthritis in the young, such as polyarticular juvenile idiopathic arthritis (PJIA) and systemic juvenile idiopathic arthritis (SJIA).
Patients taking Actemra suffered very serious and sometimes deadly infections. Some people that were exposed to TB (tuberculosis) before, but never got the infection, developed TB after starting treatment with this medicine.
Unlike many other competing RA drugs, Actemra didn’t carry a warning label about cardiovascular and pulmonary complications. This has been confirmed by an investigative news report.